Nosopharm's Loan

Nosopharm raised a round of funding on February 12, 2018. Investors include BPI France.

Nosopharm is a biotechnology company specialized in the research and development of new antimicrobial molecules. The company discovered and developed NOSO-95179, an antibiotic for the treatment of mul…

Articles about Nosopharm's Loan: